ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.840,23
0,03%
S&P 500
5.326,56
0,67%
US Dollar vs BRL
5,2869
-0,04%
Bitcoin
71.505,05
1,25%
Brent Oil
77,295
0,24%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Eisai Company Ltd (PK) (ESALY)

  7. Eisai Company Ltd (PK) (ESALY) Notícias

ESALY

Eisai (PK) (ESALY)

Eisai Company Ltd (PK)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:ESALY
DataHoraFonteTítuloCódigoCompanhia
09/01/202313:01Dow Jones NewsTrending: Biogen, Eisai Win FDA Nod for Alzheimer's DrugUSOTC:ESALYEisai Company Ltd (PK)
06/01/202319:20Dow Jones NewsADRs End Higher, Shell and Eisai Trade ActivelyUSOTC:ESALYEisai Company Ltd (PK)
30/11/202212:46Dow Jones NewsTrending: Eisai/Biogen Alzheimer's Drug Shows Positive ResultsUSOTC:ESALYEisai Company Ltd (PK)
30/11/202208:05TipRanksBiogen and Eisai’s Alzheimer’s Drug May Pose Serious Risks, Say ResearchersUSOTC:ESALYEisai Company Ltd (PK)
28/09/202214:45Dow Jones NewsDrug Companies Pursuing Alzheimer Treatments See Shares Rise WednesdayUSOTC:ESALYEisai Company Ltd (PK)
27/09/202223:05Dow Jones NewsEisai Shares Indicated Sharply Higher After Trial of Experimental Drug Slows Alzheimer's ProgressionUSOTC:ESALYEisai Company Ltd (PK)
03/08/202208:48Dow Jones NewsMerck: Two Phase 3 Keytruda Studies Miss TargetsUSOTC:ESALYEisai Company Ltd (PK)
06/07/202200:05Dow Jones NewsEisai Shares Rise Sharply After U.S. FDA Grants Priority Review for Potential Alzheimer's DrugUSOTC:ESALYEisai Company Ltd (PK)
23/12/202100:27Dow Jones NewsEisai Shares Fall Sharply After Japan Panel Seeks More Data for Aduhelm ReviewUSOTC:ESALYEisai Company Ltd (PK)
22/12/202110:26Dow Jones NewsBiogen: Japan Panel Seeks Additional Data in Aducanumab ReviewUSOTC:ESALYEisai Company Ltd (PK)
17/12/202110:00Dow Jones NewsBiogen's Alzheimer's Treatment Gets Negative CHMP OpinionUSOTC:ESALYEisai Company Ltd (PK)
29/11/202109:28Dow Jones NewsMerck, Eisai Get Europe OK for Lenvima/Keytruda Combination in Two CancersUSOTC:ESALYEisai Company Ltd (PK)
11/11/202120:40Dow Jones NewsBiogen, Eisai Alzheimer Treatment Shows Positive Signs in Advanced TrialUSOTC:ESALYEisai Company Ltd (PK)
15/10/202109:21Dow Jones NewsMerck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two CancersUSOTC:ESALYEisai Company Ltd (PK)
28/01/201620:00Dow Jones NewsFDA Approves Eisai's Halaven to Treat LiposarcomaUSOTC:ESALYEisai Company Ltd (PK)
02/09/201503:00Dow Jones NewsAmgen to Help Develop Novartis's Pipeline of Alzheimer's DrugsUSOTC:ESALYEisai Company Ltd (PK)
09/06/201512:06The Motley FoolObesity Drugs: Stocks to WatchUSOTC:ESALYEisai Company Ltd (PK)
09/04/201520:20Dow Jones NewsJapanese Drug Company Eisai to Cut 25% of U.S. JobsUSOTC:ESALYEisai Company Ltd (PK)
28/03/201513:03The Motley Fool5 Freakishly Expensive Cancer DrugsUSOTC:ESALYEisai Company Ltd (PK)
11/09/201409:50Dow Jones NewsFDA Approves Orexigen's Diet Drug ContraveUSOTC:ESALYEisai Company Ltd (PK)
16/12/201320:05ZacksPipeline Progress at Corcept - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
08/11/201320:00ZacksArena Pharma Q3 Loss Narrower than Expected - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
16/06/201323:53Dow Jones NewsASIA MARKETS: Japan Stocks Rebound As Asia Awaits Fed MeetingUSOTC:ESALYEisai Company Ltd (PK)
14/05/201307:02ZacksJazz Pharma Posts Higher Y/Y Earnings - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
06/05/201308:10ZacksArena Pharma Narrows Loss - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
23/04/201314:45ZacksData from Novartis' SPARK - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
16/04/201315:30ZacksBioLineRx to Start BL-8040 Study - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
09/04/201314:55ZacksPatients Dosed in Arena Study - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
08/03/201311:43ZacksArena Cuts Loss, Misses Estimates - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
09/11/201209:00ZacksArena Cuts Loss, Affirms Sales View - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
 Apresentando as notícias mais relevantes sobre:USOTC:ESALY

Seu Histórico Recente

BIT
Q00014
Leonteq Securities
HUOB
ENJETH
Enjin Coin
AMEX
DLN
WisdomTree US LargeCap D...
LSE
0FOD
Prodplast
ASX
AIK
LSE
0NZW
Aurea
BIT
P1YYA1
NLBNPIT1YYA1 20991231 16...
BIT
WIIT
Wiit
TG
JCSA
JPMorgan ETFS Ireland ICAV
NYSE
BBW
Build A Bear Workshop
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados